AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
This Quarter Return
+46.42%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$502M
AUM Growth
+$502M
(+64%)
Cap. Flow
+$75.9M
Cap. Flow
% of AUM
15.13%
Top 10 Holdings %
Top 10 Hldgs %
46.98%
Holding
91
New
13
Increased
21
Reduced
21
Closed
11
Top Buys
| 1 |
IMGN
Immunogen Inc
IMGN
|
$41.6M |
| 2 |
LIAN
LianBio American Depositary Shares
LIAN
|
$13.9M |
| 3 |
Celldex Therapeutics
CLDX
|
$9.92M |
| 4 |
Nuvalent
NUVL
|
$9.2M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$7.35M |
Top Sells
| 1 |
Apogee Therapeutics
APGE
|
$14.2M |
| 2 |
Kura Oncology
KURA
|
$9.56M |
| 3 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$6.57M |
| 4 |
Cytokinetics
CYTK
|
$5.87M |
| 5 |
Mersana Therapeutics
MRSN
|
$4.29M |
Sector Composition
| 1 | Healthcare | 94.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Insulet
PODD
$24.2B
| – | – |
-5,000
| Closed | -$797K |
|
77
NLS Pharmaceutics
NLSP
$9.96M
| – | – |
-200,455
| Closed | -$140K |
|
78
Milestone Pharmaceuticals
MIST
$151M
| – | – |
-335,068
| Closed | -$1.04M |
|
|
MESO
79
Mesoblast
MESO
$1.65B
| – | – |
0
| – | – |
|
80
Lantheus
LNTH
$3.75B
| – | – |
-30,000
| Closed | -$2.08M |
|
81
Inspire Medical Systems
INSP
$2.53B
| – | – |
-6,293
| Closed | -$1.25M |
|
82
Structure Therapeutics
GPCR
$1.14B
| – | – |
0
| – | – |
|
83
89bio
ETNB
$1.37B
| – | – |
0
| – | – |
|
84
BioAtla
BCAB
$28.7M
| – | – |
-180,000
| Closed | -$306K |
|
85
ARK Genomic Revolution ETF
ARKG
$1.05B
| – | – |
0
| – | – |
|
86
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
0
| – | – |
|
87
Aldeyra Therapeutics
ALDX
$350M
| – | – |
-44,348
| Closed | -$296K |
|
88
Aclaris Therapeutics
ACRS
$223M
| – | – |
0
| – | – |
|